Literature DB >> 11285304

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease.

S Pennathur1, J D Wagner, C Leeuwenburgh, K N Litwak, J W Heinecke.   

Abstract

Recent evidence argues strongly that the marked increase in risk for atherosclerotic heart disease seen in diabetics cannot be explained by a generalized increase in oxidative stress. Here, we used streptozotocin to induce hyperglycemia in cynomolgus monkeys for 6 months and tested whether high glucose levels promote localized oxidative damage to artery wall proteins. We focused on three potential agents of oxidative damage: hydroxyl radical, tyrosyl radical, and reactive nitrogen species. To determine which pathways operate in vivo, we quantified four stable end products of these reactants -- ortho-tyrosine, meta-tyrosine, o,o'-dityrosine, and 3-nitrotyrosine -- in aortic proteins. Levels of ortho-tyrosine, meta-tyrosine, and o,o'-dityrosine, but not of 3-nitrotyrosine, were significantly higher in aortic tissue of hyperglycemic animals. Of the oxidative agents we tested, only hydroxyl radical mimicked this pattern of oxidized amino acids. Moreover, tissue levels of ortho-tyrosine and meta-tyrosine correlated strongly with serum levels of glycated hemoglobin, a measure of glycemic control. We conclude that short-term hyperglycemia in primates promotes oxidation of artery wall proteins by a species that resembles hydroxyl radical. Our observations suggest that glycoxidation reactions in the arterial microenvironment contribute to early diabetic vascular disease, raising the possibility that antioxidant therapies might interrupt this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285304      PMCID: PMC199570          DOI: 10.1172/JCI11194

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages.

Authors:  D J Lamb; M J Mitchinson; D S Leake
Journal:  FEBS Lett       Date:  1995-10-23       Impact factor: 4.124

2.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.

Authors:  S P Wolff; R T Dean
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

Review 3.  Advanced protein glycosylation in diabetes and aging.

Authors:  M Brownlee
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

Review 4.  Hyperglycemic pseudohypoxia and diabetic complications.

Authors:  J R Williamson; K Chang; M Frangos; K S Hasan; Y Ido; T Kawamura; J R Nyengaard; M van den Enden; C Kilo; R G Tilton
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose.

Authors:  K J Wells-Knecht; D V Zyzak; J E Litchfield; S R Thorpe; J W Baynes
Journal:  Biochemistry       Date:  1995-03-21       Impact factor: 3.162

7.  Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

Authors:  R Bucala; Z Makita; T Koschinsky; A Cerami; H Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.

Authors:  I Giardino; D Edelstein; M Brownlee
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material.

Authors:  J Swain; J M Gutteridge
Journal:  FEBS Lett       Date:  1995-07-24       Impact factor: 4.124

Review 10.  Diabetic microvascular complications and growth factors.

Authors:  A Pfeiffer; H Schatz
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

View more
  41 in total

Review 1.  Transition metals redox: reviving an old plot for diabetic vascular disease.

Authors:  V M Monnier
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Acute hyperglycemia induces an oxidative stress in healthy subjects.

Authors:  R Marfella; L Quagliaro; F Nappo; A Ceriello; D Giugliano
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 4.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

5.  Misincorporation of free m-tyrosine into cellular proteins: a potential cytotoxic mechanism for oxidized amino acids.

Authors:  Hande Gurer-Orhan; Nuran Ercal; Suneetha Mare; Subramaniam Pennathur; Hilmi Orhan; Jay W Heinecke
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

6.  Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry.

Authors:  Anuradha Vivekanandan-Giri; Jaeman Byun; Subramaniam Pennathur
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

Review 7.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

8.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Authors:  Constanze Bergt; Subramaniam Pennathur; Xiaoyun Fu; Jaeman Byun; Kevin O'Brien; Thomas O McDonald; Pragya Singh; G M Anantharamaiah; Alan Chait; John Brunzell; Randolph L Geary; John F Oram; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

9.  Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients.

Authors:  A Ceriello; R Assaloni; R Da Ros; A Maier; L Quagliaro; L Piconi; K Esposito; D Giugliano
Journal:  Diabetologia       Date:  2004-08-14       Impact factor: 10.122

10.  Decreased nitric oxide bioavailability in a mouse model of Fabry disease.

Authors:  Liming Shu; James L Park; Jaeman Byun; Subramaniam Pennathur; Jessica Kollmeyer; James A Shayman
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.